medical oncology newsroom
.png?sfvrsn=65562b4_1 "Website Photo Squares (78)")
Funding Award Will Improve Testing of Cancer Therapies
Hatim Sabaawy, MD, PhD explains why a key initial funding award is the first step in the fulfillment of a mission. The project focuses on immunotherapies for non-small cell lung cancer (NSCLC), which represents about 80% to 85% of all diagnosed lung cancers. About 350 people in the United States die from lung cancer each day, mostly from NSCLC.
.png?sfvrsn=754461b4_1 "Website Photo Squares (75)")
Virginia Borges, MD, Discusses Advances in Breast Cancer
For 20 years, Dr. Borges has led the CU Cancer Center’s Young Women’s Breast Cancer Translational Program, and provides insight as to why breast cancer in younger women and in the first 5 to 10 years after pregnancy often are more aggressive than other breast cancers.
.png?sfvrsn=a9a765b4_1 "Website Photo Squares (72)")
Wells Messersmith, MD, Distinguished Faculty Honoree
The Distinguished Faculty Professionalism Award recognizes faculty who consistently demonstrate exemplary professional behaviors, providing service to the community, demonstrating dedication to lifelong learning, and who contribute to the teaching, service, and administrative activities of their department and the CU School of Medicine.
.png?sfvrsn=87a765b4_1 "Website Photo Squares (71)")
How Dr. Lieu's Research Helps Fuel His Clinical Care
When asked about his philosophy in caring for patients, Dr. Lieu describes three pillars: Providing compassionate care, cutting edge care, and multidisciplinary care. And always understand that the patient is your responsibility.
.png?sfvrsn=4a459abb_1 "Website Photo Squares (65)")
Hepatic Arterial Infusion Pump in Colon Cancer Treatment
Available primarily at specialized cancer centers, the HAI pump has been a lifesaver for some, but not all patients with colorectal cancer that spreads to the liver and researchers are still working to understand who will benefit most from the treatment.
.png?sfvrsn=6e2e9cbb_1 "Website Photo Squares (62)")
Launch of Innovative Program to Support Working Cancer Patients
Dr. Messersmith acknowledges the physical and emotional challenges caused by cancer are only exacerbated by financial stress when patients are unable to work which is why the WeCanWork project has such great potential.
.png?sfvrsn=ef2e9cbb_1 "Website Photo Squares (61)")
Latest Advances in Sarcoma Treatment & Patient Care
Because Sarcoma is a rare and unique disease, Dr. Wilky discusses the importance of partnering with researchers and clinicians across different disciplines to ensure patients receive a customized treatment plan and specialized care.
.png?sfvrsn=30b2dfbb_1)
Increasing Diversity Enrollment in Clinical Trials
Diverse clinical-trial participation means better science, different groups of people may respond to a given medication in different ways including efficacy and side effects. When certain populations are underrepresented in medical research, the result can be further health disparities.